Literature DB >> 16927198

Calcineurin inhibitors reduce nuclear localization of transcription factor NFAT in UV-irradiated keratinocytes and reduce DNA repair.

Matthew T Canning1, Stephanie L Nay, Arely V Peña, Daniel B Yarosh.   

Abstract

Calcineurin inhibitors are drugs used to suppress the immune system by blocking the nuclear localization of the NFAT transcription factor. Systemic use of these drugs is essential to organ transplantation, but comes at the cost of elevated rates of skin cancer. They have been used topically in atopic dermatitis and other skin diseases on the assumption that they avoid the cancer risk by localized use. The results here show that in skin cells and artificial models of human skin, calcineurin inhibitors block UV-induced nuclear localization of NFAT, and significantly reduce repair of cyclobutane pyrimidine dimers induced in DNA. In addition they inhibit apoptosis of UV-irradiated cells. The effect of blocking nuclear localization of NFAT and inhibiting DNA repair should be considered in judging the risk of topical use of calcineurin inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927198     DOI: 10.1007/s10735-006-9034-9

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  10 in total

1.  Effect of immunosuppressive therapy on DNA repair and cancer incidence in renal transplant recipients.

Authors:  T Weinstein; A Korzets; A Chagnac; Y Ori; M Herman; D Zevin; T Malachi; U Gafter
Journal:  Transplant Proc       Date:  2000-06       Impact factor: 1.066

Review 2.  Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology.

Authors:  N J Reynolds; W I Al-Daraji
Journal:  Clin Exp Dermatol       Date:  2002-10       Impact factor: 3.470

3.  p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status.

Authors:  J M McGregor; R J Berkhout; M Rozycka; J ter Schegget; J N Bouwes Bavinck; L Brooks; T Crook
Journal:  Oncogene       Date:  1997-10-02       Impact factor: 9.867

4.  Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation.

Authors:  Daniel B Yarosh; Arely V Pena; Stephanie L Nay; Matthew T Canning; David A Brown
Journal:  J Invest Dermatol       Date:  2005-11       Impact factor: 8.551

5.  Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation.

Authors:  S Vamvakas; U Bahner; P Becker; A Steinle; R Götz; A Heidland
Journal:  Transplant Proc       Date:  1996-12       Impact factor: 1.066

6.  Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.

Authors:  M Herman; T Weinstein; A Korzets; A Chagnac; Y Ori; D Zevin; T Malachi; U Gafter
Journal:  J Lab Clin Med       Date:  2001-01

7.  Involvement of nuclear factor of activated T cells activation in UV response. Evidence from cell culture and transgenic mice.

Authors:  C Huang; P Mattjus; W Y Ma; M Rincon; N Y Chen; R E Brown; Z Dong
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

8.  Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells.

Authors:  D E Pritchard; J Singh; D L Carlisle; S R Patierno
Journal:  Carcinogenesis       Date:  2000-11       Impact factor: 4.944

Review 9.  Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management.

Authors:  Daniel Berg; Clark C Otley
Journal:  J Am Acad Dermatol       Date:  2002-07       Impact factor: 11.527

10.  UV-DNA damage in mouse and human cells induces the expression of tumor necrosis factor alpha.

Authors:  J Kibitel; V Hejmadi; L Alas; A O'Connor; B M Sutherland; D Yarosh
Journal:  Photochem Photobiol       Date:  1998-05       Impact factor: 3.421

  10 in total
  5 in total

1.  NFATc1 balances quiescence and proliferation of skin stem cells.

Authors:  Valerie Horsley; Antonios O Aliprantis; Lisa Polak; Laurie H Glimcher; Elaine Fuchs
Journal:  Cell       Date:  2008-01-25       Impact factor: 41.582

2.  [Topical immunomodulation. A milestone for the treatment of therapy-resistant noninfectious chronic external otitis?].

Authors:  P P Caffier; W Harth; B Mayelzadeh; H Haupt; H Scherer; B Sedlmaier
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

3.  Oral carcinoma development after 23 years of renal transplantation.

Authors:  Isabel Schausltz Pereira Faustino; Diego Teztner Fernandes; Alan Santos-Silva; Pablo Agustin Vargas; Marcio Ajudarte Lopes
Journal:  Autops Case Rep       Date:  2019-09-18

4.  Lysophosphatidic acid promotes cell migration through STIM1- and Orai1-mediated Ca2+(i) mobilization and NFAT2 activation.

Authors:  Ralph Jans; Laura Mottram; Darren L Johnson; Anna M Brown; Stephen Sikkink; Kehinde Ross; Nick J Reynolds
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

5.  Gimap5-dependent inactivation of GSK3β is required for CD4+ T cell homeostasis and prevention of immune pathology.

Authors:  Andrew R Patterson; Mehari Endale; Kristin Lampe; Halil I Aksoylar; Aron Flagg; Jim R Woodgett; David Hildeman; Michael B Jordan; Harinder Singh; Zeynep Kucuk; Jack Bleesing; Kasper Hoebe
Journal:  Nat Commun       Date:  2018-01-30       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.